EN3356

CAS No. 1429329-63-4

EN3356( —— )

Catalog No. M34509 CAS No. 1429329-63-4

EN3356 is an orally available and selective inhibitor of steroidal 17-alpha-hydroxylase/C17,20 cleavage enzyme (CYP17A1 or CYP17), a non-steroidal cleavage enzyme-selective compound with potential anti-androgenic and anti-tumor activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 137 Get Quote
5MG 200 Get Quote
10MG 295 Get Quote
25MG 539 Get Quote
50MG 727 Get Quote
100MG 972 Get Quote
500MG 1971 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    EN3356
  • Note
    Research use only, not for human use.
  • Brief Description
    EN3356 is an orally available and selective inhibitor of steroidal 17-alpha-hydroxylase/C17,20 cleavage enzyme (CYP17A1 or CYP17), a non-steroidal cleavage enzyme-selective compound with potential anti-androgenic and anti-tumor activity.
  • Description
    EN3356 is an orally available and selective inhibitor of steroidal 17-alpha-hydroxylase/C17,20 cleavage enzyme (CYP17A1 or CYP17), a non-steroidal cleavage enzyme-selective compound with potential anti-androgenic and anti-tumor activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    P450
  • Recptor
    P450
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1429329-63-4
  • Formula Weight
    300.35
  • Molecular Formula
    C16H13FN2OS
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(C)(O)(C=1SC(=NC1)C2=CC=C(F)C=C2)C=3C=CN=CC3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • TAK-700 (Orteronel)

    Orteronel(TAK-700) was selected as a candidate for clinical evaluation.

  • Guan-fu base A

    Guanfu base A is a potent noncompetitive CYP2D6 inhibitor (Ki: 1.20 μM in HLMs; Ki: 0.37 μM for rCYP2D6). It also inhibits HERG channel current.

  • Naringin

    Naringin is a flavanone glycoside, which exerts a variety of pharmacological effects such as antioxidant activity, blood lipid lowering, anticancer activity, and inhibition of cytochrome P450 enzymes.